Business

ACW XanaMIA trial fully enrolled with 246th participant

ACW XanaMIA trial fully enrolled with 246th participant

Actinogen Medical LimitedDecember 17, 20255
ACW XanaMIA trial fully enrolled with 246th participant

About this update from Actinogen Medical Limited

Actinogen Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Actinogen Medical Limited

More from Actinogen Medical Limited

All Actinogen Medical Limited news →